help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maestrelli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maestrelli, P.
American Journal of Respiratory and Critical Care Medicine Vol 169. pp. 331-332, (2004)
© 2004 American Thoracic Society


Editorial

Natural History of Adult-Onset Asthma

Insights from Model of Occupational Asthma

Piero Maestrelli, M.D.

Department of Environmental Medicine and Public Health University of Padua Padua, Italy

Longitudinal studies from childhood to adult years have yielded risk factors for the persistence of childhood asthma (1). Yet, little is known of the natural history of adult-onset asthma. Occupational asthma has been suggested as a useful "human model" of adult extrinsic asthma (2). In this issue of the Journal (pp. 367–372), Maghni and coworkers provide evidence that patients with occupational asthma who retain their bronchial hyper-responsiveness for several years after removal from exposure to the causing agent exhibit persistent airway inflammation, characterized by eosinophilia and neutrophilia in induced sputum (3).

The study of Maghni and coworkers (3) is not solely of interest to investigators of occupational diseases, but is also of interest to most chest physicians. The wide interest is justified because occupational asthma is estimated to account for approximately 15% of the adult asthmatic population (4). Asthma remains the most commonly reported occupational lung disease in most industrialized countries. More interestingly, trends from long-standing surveillance schemes in Finland and the UK show little change in the incidence of occupational asthma over the past 10 years (5,6).

The study by Maghni and coworkers (3) offers the opportunity to employ occupational asthma as a model for studying the natural history of adult-onset asthma in general. There are advantages to using this model for that purpose: the agent causing the disease is well identified; the onset, duration, and intensity of exposure can be determined more precisely than in non-occupational asthma; complete removal of the cause of the disease is feasible, making it possible to characterize the long-term consequences of a respiratory sensitization without interference from further exposures to the inciting agent. A pioneering study by Chan-Yeung and coworkers (7) documented higher numbers of eosinophils and neutrophils in bronchoalveolar lavage fluid of 10 patients who failed to recover from western red cedar asthma after removal from exposure for at least 1 year. Investigations using bronchial biopsies revealed airway inflammation and remodeling in workers studied not very long after cessation of exposure (6–18 months) (89). Original findings of the study by Maghni and coworkers (3) include an increase in eosinophils; neutrophils, and their product, myeloperoxidase; and the neutrophil chemoattractant, interleukin-8, in subjects with persistent airway hyperresponsiveness many years after the last exposure (on average, 6.8 years). Of note, the study involved only a minimally invasive technique (induced sputum). The large number of subjects examined (103) and the lack of difference in the outcome measurements between asthma caused by high– and low–molecular weight agents suggest that these findings may represent a common feature of persistent occupational asthma.

The use of airway responsiveness to methacholine for evaluating control of asthma may seem to conflict with the recommendations of international guidelines that are based solely on symptoms and lung function. There is some evidence, however, that a treatment strategy aimed at reducing airway hyperresponsiveness is more effective in the management of asthma (10). An approach based on airway hyperresponsiveness may be further justified in a long-term study of occupational asthma because airway hyperresponsiveness tends to improve more slowly after cessation of exposure than do symptoms and lung volumes (11, 12). As a consequence of this criterion, Maghni and coworkers (3) excluded patients without measurement of airway hyperresponsiveness. The main reasons that methacholine challenge was not performed were related to the severity of asthma; accordingly, the relationships between functional outcome and inflammatory features at the time of the follow-up applies to subjects with milder asthma. Because of evidence that conditions at diagnosis strongly influence the prognosis (12), it is possible that the results would have been different had all subjects been included in the study. The ideal design of a study for prospectively assessing the consequences of occupational asthma is to include measurements of airway inflammation and lung function before and after removal from exposure to causal agents. Because sputum was not examined before cessation of exposure, the data of Maghni and coworkers (3) does not characterize the starting degree of inflammation, nor do the data indicate whether or not patients with persistent inflammation actually improved during follow-up.

Despite these limitations, the remarkable persistence of airway inflammation and its characteristics have important implications. Because reexposure to the offending agent was excluded, airway inflammation appears self-sustained (without needing a specific exogenous stimulus). Low–molecular weight chemicals responsible for occupational sensitization once inhaled may attach proteins, although these compounds are unlikely to remain in the body for years. The same consideration is even more valid when the sensitizing agent is a protein. If the mechanism of airway inflammation in these patients with persisting asthma is independent of exogenous stimulation, avoiding allergen will not be sufficient to produce a favorable outcome. The question therefore arises whether prolonged antiinflammatory therapy might benefit. A few (relatively short-term) controlled clinical trials have explored the benefit of inhaled steroids after removal from the workplace (13, 14). Various clinical and functional parameters, including bronchial hyperresponsiveness, exhibit improvement, but no case of definite cure of asthma has been documented. Most current treatment strategies are focused on eosinophilic airway inflammation. A substantial part of the inflammatory response in persistent occupational asthma, however, appears to involve interleukin-8–mediated neutrophil influx or a mixed eosinophil/neutrophil response (3). Inflammatory mechanisms not involving eosinophilic inflammation are also common in general asthma (15). Indeed, sputum neutrophils were the only cell higher in patients with severe asthma than in patients with mild to moderate asthma in a large cross-sectional European study (16). The availability of non-invasive tools for assessing airway inflammation and the model of occupational asthma may help us better understand the mechanisms responsible for asthma, and lead to the development of new treatment strategies.

FOOTNOTES

Conflict of Interest Statement: P.M. has no declared conflict of interest.

REFERENCES

  1. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:1414–1422.[Abstract/Free Full Text]
  2. Tarlo SM. Occupational asthma: a valid model for adult asthma? Curr Opin Allergy Clin Immunol 2003;3:91–94.[Medline]
  3. Maghni K, Lemière C, Ghezzo H, Yuquan W, Malo J-L. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004;169:367–372.[Abstract/Free Full Text]
  4. American Thoracic Society. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003;167:787–797.[Free Full Text]
  5. Meyer JD, Holt DL, Chen Y, Cherry NM, McDonald JC. SWORD '99: surveillance of work-related and occupational respiratory disease in the UK. Occup Med 2001;51:204–208.[Abstract]
  6. Reijula K, Haahtela T, Klaukka T, Rantanen J. Incidence of occupational asthma and persistent asthma in young adults has increased in Finland. Chest 1996;110:58–61.[Abstract/Free Full Text]
  7. Chan-Yeung M, Leriche J, Maclean L, Lam S. Comparison of cellular and protein changes in bronchoalveolar lavage fluid of symptomatic and asymptomatic patients with red cedar asthma on follow-up examination. Clin Allergy 1988;18:359–365.[CrossRef][Medline]
  8. Boulet LP, Boutet M, Laviolette M, Dugas M, Milot J, Leblanc C, Paquette L, Cote J, Cartier A, Malo JL. Airway inflammation after removal from the causal agent in occupational asthma due to high and low molecular weight agents. Eur Respir J 1994;7:1567–1575.[Abstract]
  9. Saetta M, Maestrelli P, Turato G, Mapp CE, Milani G, Pivirotto F, Fabbri LM, Di Stefano N. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Crit Care Med 1995;151:489–494.[Abstract]
  10. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbrouchke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043–1051.[Abstract/Free Full Text]
  11. Malo JL, Cartier A, Ghezzo H, Lafrance M, Mccants M, Lehrer SB. Patterns of improvement of spirometry, bronchial hyperresponsiveness, and specific IgE antibody levels after cessation of exposure in occupational asthma caused by snow-crab processing. Am Rev Respir Dis 1988;138:807–812.[Medline]
  12. Padoan M, Pozzato V, Simoni M, Zedda L, Milan G, Bononi I, Piola C, Maestrelli P, Boschetto P, Mapp CE. Long-term follow-up of toluene diisocyanate–induced asthma. Eur Respir J 2003;21:637–640.[Abstract/Free Full Text]
  13. Maestrelli P, DeMarzo N, Saetta M, Boscaro M, Fabbri LM, Mapp CE. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Am Rev Respir Dis 1993;148:407–412.[Medline]
  14. Malo J-L, Cartier A, Cote J, Milot J, Leblanc C, Paquette L, Ghezzo H, Boulet LP. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18 month double-blind cross over study. Am Rev Respir Dis 1996;153:953–960.
  15. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643–648.[Abstract/Free Full Text]
  16. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003;22:470–477.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Occup Med (Lond)Home page
N. D. Bakerly, V. C. Moore, A. D. Vellore, M. S. Jaakkola, A. S. Robertson, and P. S. Burge
Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme
Occup. Med., May 1, 2008; 58(3): 169 - 174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri
Occupational Asthma
Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maestrelli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maestrelli, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2004 American Thoracic Society